Beijing New Pharmaceutical Industry (002020.SZ) has accumulated repurchased 5.49% of shares, costing 609 million yuan.

Tencent Finance News, Jingxin Pharmaceutical (002020.SZ) announced that as of August 31, 2025, the company repurchased 47.271295 million shares of the company through centralized bidding, accounting for 5.49% of the company's current total share capital, with a total transaction amount of 609 million yuan (excluding transaction costs).